Kay Hagan actually said...

I'm concerned that duplicative regulation could slow innovation, impeding improvements to patient care as well as the job growth.

Hagan expresses concern about FDA's proposed regulation affecting innovation and job growth.

11/14/2011

More Kay Hagan Quotes

it certainly shows the efficacy of planning and then carrying it out, and building those relationships.

if these children are not born in a hospital setting, and if a midwife does the test, what is the best time to actually do that test?

The law required the CDC to write a national contingency plan with instructions for how to react in those instances.

Obviously, when you look at these fees compared to any sort of treatment, we know that the screening must take place.